---
title: "RLAY SEC Filings and Financial Statements | Tradytics"
description: "Annual income statements, balance sheets and cash flows for Relay Therapeutics (RLAY), with links to the SEC filings."
url: "https://tradytics.com/research/RLAY/fundamentals"
image: "https://tradytics.com/api/v2/og/research.png?id=RLAY&v=stock-11994860"
---

# RLAY financial statements and SEC filings

## RLAY annual income statement

| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $15.36M | -$302.74M | -$276.48M | [10-K](https://www.sec.gov/Archives/edgar/data/1812364/000119312526076739/0001193125-26-076739-index.htm) |
| 2024-12-31 | $10.01M | -$372.47M | -$337.71M | [10-K](https://www.sec.gov/Archives/edgar/data/1812364/000119312526076739/0001193125-26-076739-index.htm) |
| 2023-12-31 | $25.55M | -$373.00M | -$341.97M | [10-K](https://www.sec.gov/Archives/edgar/data/1812364/000119312526076739/0001193125-26-076739-index.htm) |
| 2022-12-31 | $1.38M | -$299.27M | -$290.51M | [10-K](https://www.sec.gov/Archives/edgar/data/1812364/000095017025027756/0000950170-25-027756-index.htm) |
| 2021-12-31 | $3.03M | -$364.70M | -$363.87M | [10-K](https://www.sec.gov/Archives/edgar/data/1812364/000095017024018797/0000950170-24-018797-index.htm) |
| 2020-12-31 | $82.65M | -$55.80M | -$52.41M | [10-K](https://www.sec.gov/Archives/edgar/data/1812364/000095017023004123/0000950170-23-004123-index.htm) |

## RLAY annual balance sheet

| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $621.33M | $54.27M | $567.06M | [10-Q](https://www.sec.gov/Archives/edgar/data/1812364/000119312526447294/0001193125-26-447294-index.htm) |
| 2024-12-31 | $871.30M | $93.50M | $777.79M | [10-K](https://www.sec.gov/Archives/edgar/data/1812364/000119312526076739/0001193125-26-076739-index.htm) |
| 2023-12-31 | $843.98M | $91.98M | $752.00M | [10-K](https://www.sec.gov/Archives/edgar/data/1812364/000095017025027756/0000950170-25-027756-index.htm) |
| 2022-12-31 | $1.10B | $149.55M | $950.22M | [10-K](https://www.sec.gov/Archives/edgar/data/1812364/000095017024018797/0000950170-24-018797-index.htm) |
| 2021-12-31 | $1.01B | $110.64M | $897.81M | [10-K](https://www.sec.gov/Archives/edgar/data/1812364/000095017023004123/0000950170-23-004123-index.htm) |
| 2020-12-31 | $799.83M | $36.54M | $763.29M | [10-K](https://www.sec.gov/Archives/edgar/data/1812364/000095017022001978/0000950170-22-001978-index.htm) |

## RLAY annual cash flow

| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | -$235.46M | -$410.00K | $1.60M | [10-K](https://www.sec.gov/Archives/edgar/data/1812364/000119312526076739/0001193125-26-076739-index.htm) |
| 2024-12-31 | -$249.11M | -$2.02M | $270.15M | [10-K](https://www.sec.gov/Archives/edgar/data/1812364/000119312526076739/0001193125-26-076739-index.htm) |
| 2023-12-31 | -$300.32M | -$4.13M | $34.75M | [10-K](https://www.sec.gov/Archives/edgar/data/1812364/000119312526076739/0001193125-26-076739-index.htm) |
| 2022-12-31 | -$229.49M | -$9.06M | $289.91M | [10-K](https://www.sec.gov/Archives/edgar/data/1812364/000095017025027756/0000950170-25-027756-index.htm) |
| 2021-12-31 | -$74.41M | -$3.47M | $388.09M | [10-K](https://www.sec.gov/Archives/edgar/data/1812364/000095017024018797/0000950170-24-018797-index.htm) |
| 2020-12-31 | -$102.49M | -$1.93M | $426.51M | [10-K](https://www.sec.gov/Archives/edgar/data/1812364/000095017023004123/0000950170-23-004123-index.htm) |

- [RLAY stock research](https://tradytics.com/research/RLAY)
- [RLAY financial summary](https://tradytics.com/research/RLAY/financials)
- [Read the data without JavaScript](https://tradytics.com/research/RLAY/fundamentals?snapshot=1)
